ID OE47 AC CVCL_4627 SY OE-47; JROECL 47; JROECL47 DR CLO; CLO_0008241 DR CLDB; cl3763 DR cancercelllines; CVCL_4627 DR Cosmic; 997862 DR ECACC; 96061336 DR Wikidata; Q54931866 RX PubMed=9010035; RX PubMed=10789716; RX PubMed=23795680; WW Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx CC Problematic cell line: Contaminated. Shown to be a HCT 116 derivative (PubMed=10789716). Originally thought to originate from a 76 year old male patient with an esophageal squamous cell carcinoma. CC Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00546. CC Population: Caucasian. CC Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line). CC Discontinued: ECACC; 96061336; true. CC Derived from site: In situ; Colon; UBERON=UBERON_0001155. DI NCIt; C4910; Colon carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0291 ! HCT 116 SX Male AG 48Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 25 // RX PubMed=23795680; DOI=10.1111/dote.12095; RA Boonstra, Jurjen J. RA Tilanus, Hugo W. RA Dinjens, Winand N.M. RT "Translational research on esophageal adenocarcinoma: from cell line RT to clinic."; RL Dis. Esophagus 28:90-96(2015). // RX PubMed=10789716; DOI=10.1054/bjoc.1999.1170; PMCID=PMC2363398; RA Wijnhoven, Bas P.L. RA Tilanus, Marcel G.J. RA Morris, Alan G. RA Darnton, S. Jane RA Tilanus, Hugo W. RA Dinjens, Winand N.M. RT "Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 RT are admixtures of the human colon carcinoma cell line HCT 116."; RL Br. J. Cancer 82:1510-1512(2000). // RX PubMed=9010035; DOI=10.1038/bjc.1997.42; PMCID=PMC2063267; RA Rockett, John C. RA Larkin, K. RA Darnton, S. Jane RA Morris, Alan G. RA Matthews, Hugoe R. RT "Five newly established oesophageal carcinoma cell lines: phenotypic RT and immunological characterization."; RL Br. J. Cancer 75:258-263(1997). //